FHI Clinical

Gold Sponsor

Information

FHI Clinical is a full-service contract research organization (CRO) with the global expertise, responsive approaches and proven solutions to manage complex clinical research in resource-limited settings around the world. Our mission is to address unmet research needs and achieve maximum social impact by supporting the development of life-saving vaccines and medicines. For more information, please refer to fhiclinical.com.

Profile
Contract Research

Social media

Contact details

+1 919 321 3321
info@fhiclinical.com
https://www.fhiclinical.com/

Sessions

Pandemic Response: Getting Ahead of the Curve

Monday, September 28, 2020 1:45 PM to 2:00 PM

Vaccinology for the 21st century in addressing emerging infectious diseases

Monday, September 28, 2020 2:00 PM to 2:30 PM

INTERACTIVE PANEL: Deploying and implementing vaccines during an outbreak: SARS-CoV-2. Challenges we've met and challenges yet to come

Monday, September 28, 2020 2:30 PM to 4:00 PM

Clinical trials of the future

Tuesday, September 29, 2020 12:30 PM to 2:00 PM

De-Risking Vaccine Clinicals Trials in Lower Resource Settings

Only 33 seats left
Wednesday, September 30, 2020 1:00 PM to 2:00 PM

Documents & Links

Case Study: Phase II/IIb Trial of a Zika Vaccine Spanning Nine CountriesAt 17 sites in 9 American and Caribbean countries, timely staffing of CRAs was enabled by our bilingual resources and knowledge of local hiring practices.
Case Study: Phase II Trial of a Chikungunya Vaccine in the CaribbeanWe maintained a 91% retention rate in a CHIKV vaccine study in 5 Caribbean countries, despite study disruptions due to natural disasters and political unrest.
Case Study: Site Monitoring & Management in Malaria Vaccine Trials in Eq. GuineaData monitoring strategies helped eliminate a backlog to ensure timely database lock in a phase 2 trial for a malaria vaccine in Equatorial Guinea.
Case Study: Study Start-Up for the STRIVE Ebola Vaccine Trial in Sierra LeoneThe project team succeeded in reaching FP/FV six weeks after arrival in Sierra Leone and 99.998% accuracy of the planned-to-execute budget.
Brochure: Vaccine DevelopmentWe’ve responded to the urgency & complexity of vaccine trials, developed our global investigator & site network, and partnered with multiple organizations.

Log in